 |
PDBsum entry 1qdd
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Metal binding protein
|
PDB id
|
|
|
|
1qdd
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Mechanism of calcite crystal growth inhibition by the n-Terminal undecapeptide of lithostathine.
|
 |
|
Authors
|
 |
V.Gerbaud,
D.Pignol,
E.Loret,
J.A.Bertrand,
Y.Berland,
J.C.Fontecilla-Camps,
J.P.Canselier,
N.Gabas,
J.M.Verdier.
|
 |
|
Ref.
|
 |
J Biol Chem, 2000,
275,
1057-1064.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Pancreatic juice is supersaturated with calcium carbonate. Calcite crystals
therefore may occur, obstruct pancreatic ducts, and finally cause a lithiasis.
Human lithostathine, a protein synthesized by the pancreas, inhibits the growth
of calcite crystals by inducing a habit modification: the rhombohedral (10 14)
usual habit is transformed into a needle-like habit through the (11 0) crystal
form. A similar observation was made with the N-terminal undecapeptide
(pE(1)R(11)) of lithostathine. We therefore aimed at discovering how peptides
inhibit calcium salt crystal growth. We solved the complete x-ray structure of
lithostathine, including the flexible N-terminal domain, at 1.3 A. Docking
studies of pE(1)R(11) with the (10 14) and (11 0) faces through molecular
dynamics simulation resulted in three successive steps. First, the undecapeptide
progressively unfolded as it approached the calcite surface. Second, mobile
lateral chains of amino acids made hydrogen bonds with the calcite surface.
Last, electrostatic bonds between calcium ions and peptide bonds stabilized and
anchored pE(1)R(11) on the crystal surface. pE(1)R(11)-calcite interaction was
stronger with the (11 0) face than with the (10 14) face, confirming earlier
experimental observations. Energy contributions showed that the peptide backbone
governed the binding more than did the lateral chains. The ability of peptides
to inhibit crystal growth is therefore essentially based on backbone flexibility.
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. A, ribbon diagram of the high resolution
structure of human lithostathine produced with the program
MOLSCRIPT (50). The elongated glycosylated N-terminal domain is
in blue, and the C-type lectin domain is in cyan. B, view of the
final (2Fo Fc)
electron density map contoured at 1 around the
O-glycosylation site of human lithostathine. The picture was
drawn using the programs BOBSCRIPT (50, 51) and RASTER3D (52).
NacGal, GalNAc.
|
 |
Figure 3.
Fig. 3. Top views of the (10 4) (A) and
(11 0)
(B) faces of calcite. On the (10 4) face,
the plane containing carbonate ions is parallel to the surface
and always exhibits an O-C-O pattern, whereas on the (11 0)
face, Y-shaped carbonate ions lie perpendicular to the surface,
presenting alternately one or two oxygen atoms. Color codes are
gray for carbon, red for oxygen, and blue for calcium atoms.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2000,
275,
1057-1064)
copyright 2000.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Crystal structure of human lithostathine, The pancreatic inhibitor of stone formation.
|
 |
|
Authors
|
 |
J.A.Bertrand,
D.Pignol,
J.P.Bernard,
J.M.Verdier,
J.C.Dagorn,
J.C.Fontecilla-Camps.
|
 |
|
Ref.
|
 |
Embo J, 1996,
15,
2678-2684.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
|
|
|
 |